Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV.

Saved in:
Bibliographic Details
Title: Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV.
Authors: Edwards S; School of Public Health, The University of Queensland, Brisbane, Australia., Puljević C; School of Public Health, The University of Queensland, Brisbane, Australia.; Centre for Health Services Research, The University of Queensland, Brisbane, Australia., Dean JA; School of Public Health, The University of Queensland, Brisbane, Australia., Gilks C; School of Public Health, The University of Queensland, Brisbane, Australia., Boyd MA; Faculty of Health & Medical Sciences, University of Adelaide, Adelaide, Australia.; Northern Adelaide Local Health Network (NALHN), Adelaide, Australia.; Kirby Institute, University of New South Wales, Sydney, Australia., Baker P; School of Public Health, The University of Queensland, Brisbane, Australia., Watts P; Queensland Positive People, Brisbane, Australia., Howard C; Queensland Positive People, Brisbane, Australia., Gartner CE; School of Public Health, The University of Queensland, Brisbane, Australia. c.gartner@uq.edu.au.
Source: AIDS and behavior [AIDS Behav] 2023 Feb; Vol. 27 (2), pp. 618-627. Date of Electronic Publication: 2022 Jul 22.
Publication Type: Journal Article
Journal Info: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9712133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3254 (Electronic) Linking ISSN: 10907165 NLM ISO Abbreviation: AIDS Behav Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-3254
DOI:10.1007/s10461-022-03797-0